<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">uzspbgmu</journal-id><journal-title-group><journal-title xml:lang="ru">Учёные записки Первого Санкт-Петербургского государственного медицинского университета имени академика И. П. Павлова</journal-title><trans-title-group xml:lang="en"><trans-title>The Scientific Notes of the Pavlov University</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1607-4181</issn><issn pub-type="epub">2541-8807</issn><publisher><publisher-name>Academician I.P. Pavlov First St. Petersburg State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24884/1607-4181-2015-22-1-34-37</article-id><article-id custom-type="elpub" pub-id-type="custom">uzspbgmu-108</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ РАБОТЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL PAPERS</subject></subj-group></article-categories><title-group><article-title>ЭКСПРЕССИЯ ГЕНОВ GR, COX2 И MMP1 В ЛЕЙКОЦИТАХ КРОВИ БОЛЬНЫХ В ПРОЦЕССЕ ТЕРАПИИ ОБОСТРЕНИЯ ХРОНИЧЕСКОЙ ОБСТРУКТИВНОЙ БОЛЕЗНИ ЛЕГКИХ</article-title><trans-title-group xml:lang="en"><trans-title>Expression of GR, COX2и MMP1 genes in peripheral blood leukocytes after intensive therapy of the patients with chronic obstructive lung disease</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Елшин</surname><given-names>Н. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Yelshin</surname><given-names>N. D.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чухловин</surname><given-names>А. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Chukhlovin</surname><given-names>A. B.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кузубова</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kuzubova</surname><given-names>N. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шаханова</surname><given-names>И. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Shahanova</surname><given-names>I. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Титова</surname><given-names>О. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Titova</surname><given-names>O. N.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">Первый Санкт-Петербургский государственный медицинский университет имени академика И. П. Павлова<country>Россия</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2015</year></pub-date><pub-date pub-type="epub"><day>30</day><month>03</month><year>2015</year></pub-date><volume>22</volume><issue>1</issue><fpage>34</fpage><lpage>37</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Елшин Н.Д., Чухловин А.Б., Кузубова Н.А., Шаханова И.А., Титова О.Н., 2015</copyright-statement><copyright-year>2015</copyright-year><copyright-holder xml:lang="ru">Елшин Н.Д., Чухловин А.Б., Кузубова Н.А., Шаханова И.А., Титова О.Н.</copyright-holder><copyright-holder xml:lang="en">Yelshin N.D., Chukhlovin A.B., Kuzubova N.A., Shahanova I.A., Titova O.N.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.sci-notes.ru/jour/article/view/108">https://www.sci-notes.ru/jour/article/view/108</self-uri><abstract><p>Цель работы - анализ экспрессии генов, контролирующих отдельные этапы воспалительного процесса при комплексной терапии хронической обструктивной болезни легких (ХОБЛ). Оценка активности генов GR, COX-2 и MMP-1 в лейкоцитах крови проводилась у 41 пациента с обострениями ХОБЛ (II - III стадия, группа D по GOLD), проходившего 2-недельный курс лечения с применением ингаляций тиотропия бромида, формотерола, глюкокортикостероидов (ГКС) и антибактериальной терапии. До и после лечения определяли содержание мРНК генов цик-лооксигеназы-2, рецепторов ГКС и матриксной металло-протеиназы-1 (СОХ2, GR, ММР-1) в лейкоцитах крови больных c применением ПЦР в реальном времени. Средние уровни экспрессии изученных генов не различались достоверно в сроки до и после лечения. Выявлены высокодостоверные корреляции между изменениями экспрессии генов СОХ2, ММР1 и GR, обратная корреляция между экспрессией генов СОХ2, GR и позитивной динамикой уровней сывороточного С-реактивного белка в процессе лечения. Результаты работы подтверждают наличие взаимосвязей между изменениями экспрессии данных генов, модулирующих процесс воспаления, и улучшением клинических показателей при комплексной лекарственной терапии ХОБЛ.</p></abstract><trans-abstract xml:lang="en"><p>Our study was aimed at analysis of expression of genes controlling individual stages of an inflammatory process in combined therapy of chronic obstructive lung disease (COPD). Evaluation of activity of GR, COX-2, and MMP1 genes in blood leukocytes was determined in forty one patients with COPD exacerbations (GOLD stage II to III, Group D) who underwent a two-week combined treatment including Tiotropium Bromide, Formoterol, and glucocotricoid inhalations, as well as parenteral antibacterial treatment. Before and after treatment, relative content of specific mRNAs for GR, GC receptors, and matrix metalloproteinase-1 (COX-2, GR, and MMP1) genes were determined with real-time PCR. Mean values of the gene expression did not significantly differ between the pre- and post-treatment time points. We have found, however, a highly significant correlation between individual changes of the СОХ2, ММР1 и GR gene expression, as well as reverse correlation between СОХ2, GR expression and positive changes in C-reactive protein levels following treatment course. The results of study confirm some interrelations between changes in expression of the inflammation-modulating genes and improvement of clinical parameters after combined drug therapy of the COPD.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>хроническая обструктивная болезнь легких</kwd><kwd>комплексная терапия</kwd><kwd>лейкоциты</kwd><kwd>экспрессия генов</kwd><kwd>СОХ2</kwd><kwd>ММР1</kwd><kwd>GR</kwd><kwd>chronic obstructive lung disease</kwd><kwd>combined therapy</kwd><kwd>leukocytes</kwd><kwd>gene expression</kwd><kwd>СОХ2</kwd><kwd>ММР1</kwd><kwd>GR</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Клемент Р. Ф. Инструкции по применению формул и таблиц должных величин основных спирометрических показателей / Р. Ф. Клемент, А. А. Лаврушин, Ю. Н. Котелов, П. А. Тер-Погосян. - Л., 1986.</mixed-citation><mixed-citation xml:lang="en">Клемент Р. Ф. Инструкции по применению формул и таблиц должных величин основных спирометрических показателей / Р. Ф. Клемент, А. А. Лаврушин, Ю. Н. Котелов, П. А. Тер-Погосян. - Л., 1986.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Agusti A., Edwards L. D., Rennard S. I. et al. Evaluation of COPD longitudinally to identify predictive surrogate endpoints (ECLIPSE) investigators. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype // PLoS One. - 2012. - № 7(5). - Р. e37483. doi:</mixed-citation><mixed-citation xml:lang="en">Agusti A., Edwards L. D., Rennard S. I. et al. Evaluation of COPD longitudinally to identify predictive surrogate endpoints (ECLIPSE) investigators. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype // PLoS One. - 2012. - № 7(5). - Р. e37483. doi:</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">/journal. pone. 0037483.</mixed-citation><mixed-citation xml:lang="en">/journal. pone. 0037483.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Blidberg K., Palmberg L., Dahlen B.et al. Increased neutrophil migration in smokers with or without chronic obstructive pulmonary disease // Respirology. - 2012. - Vol. 17 (5). - P. 854-860.</mixed-citation><mixed-citation xml:lang="en">Blidberg K., Palmberg L., Dahlen B.et al. Increased neutrophil migration in smokers with or without chronic obstructive pulmonary disease // Respirology. - 2012. - Vol. 17 (5). - P. 854-860.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">. Cavalcante L. O., Melo M. R., Dinis V. G. et al. Quantitation of glucocorticoid receptor alpha and NF-кВ pathway mRNA and its correlation with disease activity in rheumatoid arthritis patients // Genet. Mol. Res. - 2010. - Vol. 9 (4). - P. 2300-2310</mixed-citation><mixed-citation xml:lang="en">. Cavalcante L. O., Melo M. R., Dinis V. G. et al. Quantitation of glucocorticoid receptor alpha and NF-кВ pathway mRNA and its correlation with disease activity in rheumatoid arthritis patients // Genet. Mol. Res. - 2010. - Vol. 9 (4). - P. 2300-2310</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Churg A., Zhou S., Wright J. L. Series «matrix metalloproteinases in lung health and disease»: Matrix metallopro-teinases in COPD // Eur. Respir. J. - 2012. - Vol. 39 (1). - P. 197 - 209.</mixed-citation><mixed-citation xml:lang="en">Churg A., Zhou S., Wright J. L. Series «matrix metalloproteinases in lung health and disease»: Matrix metallopro-teinases in COPD // Eur. Respir. J. - 2012. - Vol. 39 (1). - P. 197 - 209.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Gao P., Zhang J., He X. et al. Sputum inflammatory cell-based classification of patients with acute exacerbation of chronic obstructive pulmonary disease // PLoS One. - 2013. - № 8(5). - Р. e57678. doi: 10. 1371/journal. pone. 0057678.</mixed-citation><mixed-citation xml:lang="en">Gao P., Zhang J., He X. et al. Sputum inflammatory cell-based classification of patients with acute exacerbation of chronic obstructive pulmonary disease // PLoS One. - 2013. - № 8(5). - Р. e57678. doi: 10. 1371/journal. pone. 0057678.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Hackett T. L. Dynamics of pro-inflammatory and antiinflammatory cytokine release during acute inflammation in chronic obstructive pulmonary disease: an ex vivo study / T. L. Hackett, R. Holloway, S. T. Holgate, J. A. Warner // Respir. Res. - 2008. - № 9. - Р. 47. doi: 10. 1186/1465-9921-9-47.</mixed-citation><mixed-citation xml:lang="en">Hackett T. L. Dynamics of pro-inflammatory and antiinflammatory cytokine release during acute inflammation in chronic obstructive pulmonary disease: an ex vivo study / T. L. Hackett, R. Holloway, S. T. Holgate, J. A. Warner // Respir. Res. - 2008. - № 9. - Р. 47. doi: 10. 1186/1465-9921-9-47.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Jordan R. C. K., Macabeo-Ong M., Shiboski C. H. et al. Overexpression of matrix metalloproteinase-1 and -9 mRNA is associated with progression of oral dysplasia to cancer overexpression of matrix metalloproteinase-1 and -9 mRNA // Clin. Cancer Res. - 2004. - Vol. 10. - P. 6460 - 6465.</mixed-citation><mixed-citation xml:lang="en">Jordan R. C. K., Macabeo-Ong M., Shiboski C. H. et al. Overexpression of matrix metalloproteinase-1 and -9 mRNA is associated with progression of oral dysplasia to cancer overexpression of matrix metalloproteinase-1 and -9 mRNA // Clin. Cancer Res. - 2004. - Vol. 10. - P. 6460 - 6465.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Patel N., Itakura T., Gonzalez J. M. Jr. et al. GPR158, an Orphan Member of G Protein-Coupled Receptor Family C: Glucocorticoid-stimulated expression and novel nuclear role // PLoS ONE. - 2013. - № 8 (2). e57843. doi:10. 1371/journal. pone. 0057843</mixed-citation><mixed-citation xml:lang="en">Patel N., Itakura T., Gonzalez J. M. Jr. et al. GPR158, an Orphan Member of G Protein-Coupled Receptor Family C: Glucocorticoid-stimulated expression and novel nuclear role // PLoS ONE. - 2013. - № 8 (2). e57843. doi:10. 1371/journal. pone. 0057843</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Plumb J., Gaffey K., Kane B. et al. Reduced glucocorticoid receptor expression and function in airway neutrophils // Int. Immunopharmacol. - 2012. - Vol. 12(1). - P. 26 - 33.</mixed-citation><mixed-citation xml:lang="en">Plumb J., Gaffey K., Kane B. et al. Reduced glucocorticoid receptor expression and function in airway neutrophils // Int. Immunopharmacol. - 2012. - Vol. 12(1). - P. 26 - 33.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Roh G. S., Yi C. O., Cho Y. J. et al. Anti-inflammatory effects of celecoxib in rat lungs with smoke-induced emphysema // Am. J. Physiol. Lung Cell. Mol. Physiol. - 2010. - Vol. 299 (2). - P. L184 - L191.</mixed-citation><mixed-citation xml:lang="en">Roh G. S., Yi C. O., Cho Y. J. et al. Anti-inflammatory effects of celecoxib in rat lungs with smoke-induced emphysema // Am. J. Physiol. Lung Cell. Mol. Physiol. - 2010. - Vol. 299 (2). - P. L184 - L191.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Roy K., Smith J., Kolsum U. et al. COPD phenotype description using principal components analysis. // Respir. Res. - 2009. - № 10. - Р. 41. doi: 10. 1186/1465-9921-10-41.</mixed-citation><mixed-citation xml:lang="en">Roy K., Smith J., Kolsum U. et al. COPD phenotype description using principal components analysis. // Respir. Res. - 2009. - № 10. - Р. 41. doi: 10. 1186/1465-9921-10-41.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Xaubet A., Roca-Ferrer J., Pujols L. et al. Cyclooxygenase-2 is up-regulated in lung parenchyma of chronic obstructive pulmonary disease and down-regulated in idiopathic pulmonary fibrosis // Sarcoidosis. Vasc. Diffuse Lung Dis. - 2004. - Vol. 21(1). - P. 35 - 42.</mixed-citation><mixed-citation xml:lang="en">Xaubet A., Roca-Ferrer J., Pujols L. et al. Cyclooxygenase-2 is up-regulated in lung parenchyma of chronic obstructive pulmonary disease and down-regulated in idiopathic pulmonary fibrosis // Sarcoidosis. Vasc. Diffuse Lung Dis. - 2004. - Vol. 21(1). - P. 35 - 42.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Xi H., Baldus S. E., Warnecke-Eberz U. et al. High cyclooxygenase-2 expression following neoadjuvantradiochemotherapy is associated with minor histopathologic response and poor prognosis in esophageal cancer. // Clin. CancerRes. - 2005. - Vol. 11. - P. 8341 - 8347.</mixed-citation><mixed-citation xml:lang="en">Xi H., Baldus S. E., Warnecke-Eberz U. et al. High cyclooxygenase-2 expression following neoadjuvantradiochemotherapy is associated with minor histopathologic response and poor prognosis in esophageal cancer. // Clin. CancerRes. - 2005. - Vol. 11. - P. 8341 - 8347.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
